Press release
Postmenopausal Osteoporosis Therapeutics Market Size will Observe Substantial Growth by 2021
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The currently available technologies fail to cure postmenopausal osteoporosis completely and thus healthcare professionals prefer medicinal therapy for treatment of postmenopausal osteoporosis.View Report Preview@ https://www.persistencemarketresearch.com/market-research/postmenopausal-osteoporosis-therapeutics-market.asp
Considering the relation of age in postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market. While high standards for approval of any new product to launch into the market, competition from the emerging alternative technologies and intense competition from generics are restraining growth of this market. Mergers and acquisitions taking place in the market is one of the major restraining force of postmenopausal osteoporosis therapeutics market.
Based on the type of medicines used, postmenopausal osteoporosis therapeutics market is segmented as follows:
Bisphosphonates
Hormones
Strontium ranelate
Raloxifene
Denosumab
Others
Geographically, the global postmenopausal osteoporosis therapeutics market is segmented into:
North America
Europe
Asia Pacific
Rest of the World
Currently, North America dominates the postmenopausal osteoporosis therapeutics market and is closely followed by Europe. Asia-Pacific is a lucrative regional market for such drugs considering factors such as increasing healthcare spending and improving healthcare infrastructure.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/5882
Gradual; development of the medical tourism industry in the region is also expected to further spur the growth of postmenopausal osteoporosis therapeutics market in Asia-Pacific. Some of the major companies contributing to the global postmenopausal osteoporosis therapeutics market are Eli Lilly, Pfizer, Inc., F. Hoffman La Roche, Procter & Gamble and Merck.
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact Us
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postmenopausal Osteoporosis Therapeutics Market Size will Observe Substantial Growth by 2021 here
News-ID: 868248 • Views: …
More Releases from Persistence Market Research
Europe Textile Recycling Market to Reach US$ 2,966.5 Mn by 2032: Growth Driven b …
The Europe textile recycling market is undergoing a remarkable transformation as the region embraces sustainability, circular economy practices, and eco-conscious consumer behavior. Textile recycling-once a niche concept-has now become an integral part of Europe's strategy to reduce waste, conserve resources, and promote ethical fashion. Driven by government initiatives, growing awareness of textile waste's environmental impact, and technological innovation, the market is poised for steady growth in the coming years.
According to…
Agricultural Microbial Market to Reach US$ 17.47 Bn by 2032: Growth Driven by Su …
The agricultural microbial market is gaining remarkable traction as global farming practices shift toward sustainability, efficiency, and soil health improvement. Microbials-comprising beneficial bacteria, fungi, viruses, and protozoa-play a vital role in promoting plant growth, enhancing nutrient uptake, and protecting crops from diseases. With the world facing mounting pressure to increase agricultural productivity while minimizing environmental impact, microbial-based products are emerging as essential tools for modern agriculture.
According to the latest study…
Pine-derived Chemicals Market to Reach US$ 8.7 Bn by 2032, Driven by Rising Dema …
The global pine-derived chemicals market is witnessing steady growth as industries increasingly shift toward bio-based, renewable, and sustainable raw materials. Derived from pine trees, these chemicals-such as rosin, turpentine, and tall oil-are used in a variety of industrial and consumer applications, ranging from adhesives and coatings to food, pharmaceuticals, and personal care products. With growing awareness about environmental sustainability and the circular economy, pine-derived chemicals are gaining prominence as natural…
Bio-succinic Acid Market to Reach US$ 415.3 Mn by 2032: Growth Driven by Rising …
The bio-succinic acid market is rapidly emerging as a key component of the global bio-based chemical industry, owing to its versatile applications and sustainable production process. Bio-succinic acid, derived from renewable feedstocks such as sugar, corn, and agricultural waste, serves as a sustainable alternative to petrochemical-based succinic acid. Its eco-friendly nature, combined with rising concerns over carbon emissions and fossil fuel depletion, has made it increasingly popular across multiple industries.
According…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
